Skip to content Skip to navigation

FDA Launches Competition for Development of Naloxone App

September 20, 2016
by Heather Landi
| Reprints

In an effort to spur innovation around the development of a mobile phone app to help combat opioid overdose, the Food and Drug Administration (FDA) has launched a Naloxone App Competition.

The competition encourages computer programmers, public health advocates, clinical researchers, entrepreneurs and innovators to develop a low-cost, scalable, crowd-sourced mobile app that connect carriers of naloxone, a medication that reverses the effects of opioid overdose, with nearby opioid overdose victims. According to the FDA, such an app would help increase the likelihood that opioid users and first responders are able to identify and react to an overdose by administering naloxone.

Registration for the competition opens September 23 at https://www.challenge.gov/list/, and the competition closes on Nov. 7. The highest-scoring entrant will receive an award of $40,000.

According to the U.S. Department of Health and Human Services (HHS), in 2014, nearly 2 million Americans aged 12 years or older either abused or were dependent on opioid painkillers. In 2014, 61 percent of drug overdose deaths involved either an opioid painkiller or heroin. Between 2013 and 2014, deaths from any opioid increased 14 percent.

According to a document filed by HHS in the federal register, HHS officials state that even with naloxone increasingly available in the community, persons carrying naloxone may not be on hand when an opioid overdose occurs. “There is still the practical need to connect the individual experiencing the opioid overdose quickly and effectively with an individual carrying naloxone. Mobile phone applications (apps) have been developed to educate laypersons on opioid overdose and administration of naloxone, and to connect bystanders with individuals in need of other medical services.”

HHS officials also stated that in a randomized, controlled trial, researchers demonstrated that a mobile-phone positioning system to dispatch laypersons trained in cardiopulmonary resuscitation (CPR) was associated with significantly increased numbers of bystander-initiated CPR procedures on persons with out-of-hospital cardiac arrest.

 

Get the latest information on Mobile Health and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Califf to Lead Patient-Centered Research Foundation

Robert Califf, M.D., who stepped down as commissioner of the U.S. Food and Drug Administration in January, has been named chair of a new nonprofit organization, the People-Centered Research Foundation.

U.S. Lags on Adoption of Telehealth, According to Survey of Physicians

Only 4 percent of U.S.-based physicians think that their state has done “very well” implementing telehealth technologies and only 15 percent responded “well” when evaluating their state’s efforts to implement telehealth, according to a survey by Sermo.

CDC Survey: Cardiologists, Neurologists Have Highest EHR Adoption Rates

According to the Center for Disease Control and Prevention’s (CDC) National Electronic Health Records Survey, office-based cardiologists and neurologists have the highest electronic health record (EHR) adoption rates by specialty, at 95.6 percent and 94.5 percent, respectively.

UPMC Rolls out Telemedicine App for Pennsylvania Patients with 24/7 Service

UPMC (University of Pittsburgh Medical Center) Health Plan recently launched a new smartphone-enabled UPMC AnywhereCare platform that allows patients to receive remote care from emergency room professionals 24 hours a day and with reduced copays.

AHRQ Seeking Data on Use of Telehealth for Acute and Chronic Care Consultations

The Agency for Healthcare Research and Quality (AHRQ) is calling for public data on projects that have examined the value of telehealth for acute and chronic care.

Precision Cancer Medicine Building at UCSF Mission Bay Gets Approved

The UCSF (University of California San Francisco) Medical Center at Mission Bay’s Precision Cancer Medicine Building (PCMB) was approved by the University of California Board of Regents, and is on track to open in 2019.